Moderna shares are up following reports that the pharmaceutical giant is in the early stages of developing a hantavirus vaccine. This comes after a serious outbreak on a cruise ship. The highly contagious hantaviruses are rodent-borne diseases that cause severe respiratory reactions in humans.